Search results
Liverpool and Man City to Battle it Out for Joshua Kimmich
GiveMeSport· 6 days agoLiverpool have turned their attention to Bundesliga star Joshua Kimmich in the hunt for a new...
Inside The Ultimate $127,000 Luxury Whisky Weekend
Forbes· 5 days agoThe three night stay will set you back $127,000 (£100,000) and as well as allowing you to own the Macallan Horizon whisky it is sure to be an...
Yen rallies as election day is here
The Forex Market· 2 days agoEuropean and UK stocks are set to open higher on Thursday, after US stocks reached fresh records on Wednesday. The driver was a surge in expectations for...
England problems for Gareth Southgate to fix ahead of Switzerland Euro 2024 quarter-final after...
Sky Sports· 5 days agoEngland have booked a date with Switzerland in the quarter-finals after a woeful performance against...
US Consumer Confidence dropped, US Manufacturing goods orders fell, Canada’s and Australia’s...
The Forex Market· 4 days agoU.S. consumer confidence eased in June amid worries about the economic outlook. The Conference...
5 Best MLB First Pitches Thrown by NBA Stars
GiveMeSport· 3 days agoWhile not the actual first pitch of the game, it is a ceremonial tradition before the game itself and usually involves celebrities and prominent figures...
Sir Alex explains why Euro 2024 should be Cristiano Ronaldo's last international tournament
GiveMeSport· 3 days agoSir Alex Ferguson has made a major prediction on Cristiano Ronaldo’s future, claiming that Euro 2024...
Euro-Zone Inflation Slows as Lagarde Plays for Time on Rates
Bloomberg via Yahoo Finance UK· 4 days ago(Bloomberg) -- Euro-zone inflation slowed in June — adding to evidence that price pressures are...
Securing IoT/OT environments: The password paradox
TechRadar· 2 days agoPasswords have been our trusty guardians in the digital world, securing everything from social media accounts to bank information. With the growing...
New Drug Approved for Early Alzheimer’s
New York Times· 4 days agoThe Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted...
